Epizyme (EPZM) PT Raised to $24 at Wedbush
Tweet Send to a Friend
Wedbush raised its price target on Epizyme (NASDAQ: EPZM) to $24.00 (from $21.00) while maintaining a Outperform rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
